News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Results of Phase I/II Clinical Trial of Diffusion Pharmaceuticals' Trans Sodium Crocetinate in Patients with Peripheral Artery Disease (PAD) to be Presented at American Heart Association Scientific Sessions


11/15/2010 12:14:57 PM

(BUSINESS WIRE)--Diffusion Pharmaceuticals What: AHA Abstract #12341 Oral Presentation – “Evaluation of Trans Sodium Crocetinate on Safety and Exercise Performance in Patients with Peripheral Artery Disease and Intermittent Claudication.”

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES